期刊文献+

VEGF-C、Flt-4蛋白和LVD、Flt-4阳性脉管数在乳腺癌组织中的表达及临床意义

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C,Flt-4, LYMPHATIC-VESSEL DENSITY AND Flt-4 POSITIVE VESSEL NUMBER IN BREAST CANCE R AND ITS CLINICAL SIGNIFICANCE
下载PDF
导出
摘要 目的探讨乳腺癌组织中血管内皮生长因子-C(vascular endothelial growth factor-C,VEGF-C)、fms-样酪氨酸激-酶4(fms-like tyrosine kinase-4,Flt-4)、淋巴管密度(lymphatic-vessel density,LVD)及Flt-4阳性脉管数(Flt-4positivenumber)4指标之间的相互关系及其临床意义。方法采用链霉卵白素-过氧化物酶(streptavidin-horseradish peroxidase,SP)免疫组织化学法,检测105例乳腺癌石蜡标本中VEGF-C、Flt-4、LVD及Flt-4阳性脉管数的表达水平。结果VEGF-C与Flt-4有密切关系(P<0.01),且二者均与Flt-4阳性脉管数及LVD有密切关系(P<0.01);在淋巴结转移组中,VEGF-C和Flt-4表达水平及LVD均显著高于无淋巴结转移组(P<0.05);VEGF-C的阳性表达与乳腺癌血行转移危险密切相关(P<0.01)。结论VEGF-C、Flt-4促进淋巴管生成,且二者有显著相关性;VEGF-C、Flt-4及LVD与淋巴结转移状况密切相关,VEGF-C可能是乳腺癌患者发生血行转移的危险因素。 Objective To study the expression of vescular endothelial growth factor-C (VEGF-C) ,fins-like tyrosine kinase-4(Flt-4), lymphatic-vessel density(LVD) and Flt-4 positive vessel number in breast cancer, as well as their relationship and clinical significance. Methods Streptavidin-horseradish peroxidase (SP) immunohistochemical staining was used to detect the expression of VEGF-C, Flt-4, LVD and Flt-4 positive vessel number in 105 cases of primary breast cancer. Results VEGF-C level was significantly related to Flt-4 level( P〈0.01). Moreover, they all had significant correlation with LVD and Flt-4 positive vessel number( P〈0.01) ,respectively. The expression of VEGF-C, Flt-4 and LVD in lymph node metastasis group was significantly higher than that of no lymph node metastasis group( P〈0.05), respectively. The expression of VEGF-C in breast cancer was closely related to blood metastasis. Conclusion VEGF-C and Flt-4 promote lymphangiogenesis,moreover, VEGF-C was significantly related to Flt-4. VEGF-C,Flt-4 and LVD are closely related to lymph node metastasis, VEGF-C is probably a dangerous factor in patients who had blood metastasis.
出处 《河北医科大学学报》 CAS 2005年第5期329-332,共4页 Journal of Hebei Medical University
关键词 乳腺肿瘤 内皮生长因子 蛋白质酪氨酸激酶 肿瘤转移 免疫组织化学 breast neoplasms endothelial growth factor protein-tyrosine kinase neoplasm metastasis immunohistochemistry
  • 相关文献

参考文献15

  • 1刘毅,崔杰,张俊坤,曹道成,后强,张世和,赵仲伟,叶晓霞,石岚.VEGF、VEGF-C、flt-4在乳腺癌组织中的表达及临床病理分析[J].中国癌症杂志,2003,13(4):326-328. 被引量:5
  • 2Kinoshita J,Kitamura K,Kabashima A,et al.Clinical significance of vascular endothelial growth factor-C(VEGF-C) in breast cancer[J].Breast Cancer Res Treat,2001,66(2):159-164.
  • 3Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma[J].Natl Cancer Inst,1992,84(24):1875-1887.
  • 4Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt-4 (VEGFR3) and KDR (VEGFR2) receptor tyrosine kinases [J]. EMBO J,1996,15(2):290-298.
  • 5Makinen T, Jussola L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 [J]. Nature Medicine,2001,7(2):199-205.
  • 6Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis [J]. Nature Medicine, 2001,7(2):192-198.
  • 7Lee J,Gray A,Yuan J,et al. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt-4[J].Proc Natl Acad Sci USA,1996,93(5):1988-1992.
  • 8Cao Y,Linden P,Farnebo J,et al. Vascular endothelial growth factor C induces angiogenesis in vivo[J]. Proc Natl Acad Sci USA,1998,95(24):14389-14394.
  • 9Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer [J]. Clinical Cancer Research,1999,5(7):1823-1829.
  • 10Tsurusakl T, Kanda S, Sakal H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis[J]. British Cancer,1999,80(12):309-313.

二级参考文献12

  • 1Fleming ST, Rastogi A, Demtrienko A, et al. A comprehensive prognostic index to predict survival based on multiple comborbidities: a focus in breast cancer[J]. Mett Care, 1999,37(6) :601-604.
  • 2Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nature Med,2001,7(2) :192-198.
  • 3Karpanen T, Egeblad N, Karkkainen M J, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth[J]. Cancer Res,2001,61 ( 5 ) :1786-1790.
  • 4Peppers MS. Lymphangiogenesis and tumor metastasis: myth or reality[J] ? Clin Cancer Res,2001,7(3) :462-468.
  • 5Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis[ J ]. Physiol Rev,2002,82( 3 ) :673-700.
  • 6Stimpfl M, Tong D, Fasching B, et al. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer [J]. Clin Cancer Res,2002,8(7):2253-2259.
  • 7Nakamura M, Abe Y, Tokunaga T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer[J]. Pathol Int,2002,52( 5-6 ) :331-339.
  • 8Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothefial growth factor, VEGF-C, is a ligand for the Flt-4(VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases[J]. EMBO J,1996,15(2) :290-298.
  • 9Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis[J]. Oncogene,2000,19(49) :5598-5605.
  • 10Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice[J]. Science,1997, 276(5317):1423-1425.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部